CD33 and neoplasm: Irrespective of the treatment, T cells were the predominant immune cell population in the tumor in JIMT-1 and MDA-MB-231 mice, whereas CD33+ myeloid cells constituted the most prevalent population in MCF-7 tumors (Figure 3C).